Search results
Results From The WOW.Com Content Network
Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval for the expanded use of pimavanserin in the ...
Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
For premium support please call: 800-290-4726 more ways to reach us
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM). Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a K i of 5 nM, and no significant affinity for any other receptors tested.
What: Shares of ACADIA Pharmaceuticals -- a. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail. Sign in. Subscriptions ...
Talk. : Acadia Pharmaceuticals. This is the talk page for discussing improvements to the Acadia Pharmaceuticals article. This is not a forum for general discussion of the article's subject. Click here to start a new topic. Assume good faith. Be polite and avoid personal attacks. Be welcoming to newcomers.
For premium support please call: 800-290-4726 more ways to reach us
Acadia Pharmaceuticals Inc. (ACAD) has announced that it has filed a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential new indication ...